← FDA Drug Approvals (Drugs@FDA)

EXALGO

NDA · New Drug Application · Sponsor: SPECGX LLC · Approved 2010-03-01

Drug application

FDA Application #

NDA021217

Application type

New Drug Application

Brand name

EXALGO

Generic name

Hydromorphone Hydrochloride

Active ingredients

HYDROMORPHONE HYDROCHLORIDE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

SPECGX LLC

First approval

2010-03-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown